{{Rsnum
|rsid=11944965
|Chromosome=4
|position=62558371
|Orientation=plus
|GMAF=0.4174
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.6 | 46.0 | 12.4
| HCB | 5.8 | 52.6 | 41.6
| JPT | 7.1 | 44.2 | 48.7
| YRI | 51.0 | 42.2 | 6.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 5.8 | 52.6 | 41.6
| CHD | 9.2 | 49.5 | 41.3
| GIH | 38.6 | 48.5 | 12.9
| LWK | 39.1 | 42.7 | 18.2
| MEX | 56.9 | 31.0 | 12.1
| MKK | 37.8 | 44.9 | 17.3
| TSI | 51.0 | 40.2 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=2E-6
  |OR=1.99
  |ORtxt=[1.475-2.676]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}